![Katja Ruijs-van Rossum](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historique de carrière de Katja Ruijs-van Rossum
Anciens postes connus de Katja Ruijs-van Rossum
Sociétés | Poste | Début | Fin |
---|---|---|---|
Residex BV
![]() Residex BV Investment ManagersFinance Residex BV is a private equity and venture capital fund manager based in Apeldoorn, Netherlands. Residex traces their history to 1987 when the firm was set up as Participatiemaatschappij BV in The Hague. The current firm was formally established in 1991. Residex is a subsidiary of Achmea Holding NV which provides insurance and financial services. The ultimate parent firm is Eureko BV, which offers insurance services as well as asset management and banking services. Since 1996, Residex focuses on investments in the healthcare sector and specializes in expansion capital, MBOs, MBIs and re-structuring transactions. They manage a number of venture funds with a healthcare/life sciences focus as well as those in biotechnology and the pharmaceutical industries. | Directeur-Opérations de Back Office | 01/01/2008 | 01/01/2012 |
Statistiques
Internationale
Pays-Bas | 2 |
Opérationnelle
Director-Back Office Operation | 1 |
Sectorielle
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Residex BV
![]() Residex BV Investment ManagersFinance Residex BV is a private equity and venture capital fund manager based in Apeldoorn, Netherlands. Residex traces their history to 1987 when the firm was set up as Participatiemaatschappij BV in The Hague. The current firm was formally established in 1991. Residex is a subsidiary of Achmea Holding NV which provides insurance and financial services. The ultimate parent firm is Eureko BV, which offers insurance services as well as asset management and banking services. Since 1996, Residex focuses on investments in the healthcare sector and specializes in expansion capital, MBOs, MBIs and re-structuring transactions. They manage a number of venture funds with a healthcare/life sciences focus as well as those in biotechnology and the pharmaceutical industries. | Finance |
- Bourse
- Insiders
- Katja Ruijs-van Rossum
- Expérience